Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 22, Issue 4
Clinicians should assess the benefits and risks of using bezlotoxumab for reducing the risk of recurrent Clostridium difficile infection
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Therapeutics/Prevention
Randomised controlled trial
Clinicians should assess the benefits and risks of using bezlotoxumab for reducing the risk of recurrent
Clostridium difficile
infection
Online download statistics by month:
Online download statistics by month: July 2017 to February 2024
Abstract
Full
Pdf
Jul 2017
408
32
29
Aug 2017
555
57
20
Sep 2017
682
21
11
Oct 2017
193
16
5
Nov 2017
100
16
4
Dec 2017
54
9
5
Jan 2018
65
3
0
Feb 2018
67
6
4
Mar 2018
83
13
8
Apr 2018
42
3
1
May 2018
46
2
1
Jun 2018
63
4
3
Jul 2018
49
2
1
Aug 2018
48
2
0
Sep 2018
80
5
3
Oct 2018
19
3
0
Nov 2018
46
6
3
Dec 2018
23
0
0
Jan 2019
57
5
3
Feb 2019
24
3
1
Mar 2019
31
4
3
Apr 2019
11
2
2
May 2019
14
0
3
Jun 2019
31
1
4
Jul 2019
46
4
5
Aug 2019
20
3
0
Sep 2019
23
0
0
Oct 2019
30
0
0
Nov 2019
5
1
0
Dec 2019
29
1
1
Jan 2020
20
1
3
Feb 2020
35
1
1
Mar 2020
8
0
0
Apr 2020
10
0
2
May 2020
19
0
0
Jun 2020
7
1
2
Jul 2020
30
1
0
Aug 2020
6
0
0
Sep 2020
34
0
0
Oct 2020
36
1
0
Nov 2020
18
0
0
Dec 2020
18
3
1
Jan 2021
23
2
1
Feb 2021
20
0
0
Mar 2021
10
2
0
Apr 2021
16
1
3
May 2021
27
0
0
Aug 2021
4
0
0
Sep 2021
3
3
1
Oct 2021
26
1
0
Nov 2021
14
0
0
Dec 2021
28
1
0
Jan 2022
30
0
0
Feb 2022
31
1
0
Mar 2022
21
1
1
Apr 2022
42
0
1
May 2022
48
1
0
Jun 2022
42
0
0
Jul 2022
38
0
0
Aug 2022
55
2
0
Sep 2022
55
0
2
Oct 2022
69
1
0
Nov 2022
72
2
1
Dec 2022
19
0
0
Jan 2023
18
0
0
Feb 2023
57
0
1
Mar 2023
9
2
1
Apr 2023
7
0
0
May 2023
18
0
0
Jun 2023
6
0
0
Jul 2023
13
0
0
Aug 2023
10
0
0
Sep 2023
10
0
0
Oct 2023
14
0
0
Nov 2023
37
2
0
Dec 2023
35
0
0
Jan 2024
27
1
1
Feb 2024
23
1
2
Total
4162
256
144
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?